IFNA1 and major depressive disorder: Further analysis of increased numbers of multicenter RCTs with larger sample sizes are warranted to evaluate comprehensively the true value of prophylactic SSRIs to prevent PEG-IFN-α/RBV-associated depression during antiviral therapy in patients with CHC.